Verification register Bio, Health & Neuro
Living definition
What is PEARL Rapamycin Longevity Trial?
Longevity & Aging Biotech Bio, Health & Neuro
- As of
- 2026-09-22
- Revision
- 2026-10-06.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
The PEARL Rapamycin Longevity Trial is a clinical study testing whether low, intermittent doses of the drug rapamycin can slow measures of biological aging in healthy adults.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-09-22, verified readiness is 33 (claimed 45, reported 38, gap 12) — Strong evidence strength; current signals suggest Proceed with caution.
The readiness fact belongs to the canonical Readiness Verdict for PEARL Rapamycin Longevity Trial.
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06